Rchr
J-GLOBAL ID：201801011996009068
Update date: Apr. 29, 2024
Sasagu Kurozumi
クロズミ ササグ | Sasagu Kurozumi
Affiliation and department：
Job title：
Associate professor
Other affiliations (1)：
Research field (3)：
Human pathology
, Medical systems
, General surgery, pediatric surgery
Research keywords (5)：
Medical oncology
, Pathology
, Artificial intelligence
, Bioinformatics
, breast cancer
Research theme for competitive and other funds (5)：
- 2023 - 2026 Study concerned with breast reconstruction by lipo-transfer assisted with mesenchymal stem cells from induced pluripotent stem cell
- 2021 - 2024 Exploratory research into pathobiology mechanisms of cardiotoxicity in the trans-omics cohort of breast cancer patients treated with chemotherapy
- 2020 - 2023 Development of an innovative tool with artificial intelligence to predict the treatment response for breast cancer
- 2017 - 2020 Critical role of TGF-beta for functional switch in cancer invasion
- 2016 - 2017 乳癌の術前内分泌治療に対する応答・抵抗性を規定するmicroRNAの同定
Papers (74)：
-
Eriko Narusawa, Sasagu Kurozumi, Ayaka Katayama, Yukio Koibuchi, Akira Ogawa, Daisuke Takata, Shoko Tokuda, Sayaka Obayashi, Tetsunari Oyama, Jun Horiguchi, et al. Utility of human epidermal growth factor 2 heterogeneity as a prognostic factor in triple-negative breast cancer. Medical molecular morphology. 2024
-
Toru Hanamura, Kozue Yokoyama, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Mayako Terao, Takuho Okamura, Nobue Kumaki, Katsuto Hozumi, Takayuki Iwamoto, et al. Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment. Cancer immunology, immunotherapy : CII. 2024. 73. 3. 42-42
-
Chikako Kanno Honda, Sasagu Kurozumi, Takaaki Fujii, Didier Pourquier, Lakhdar Khellaf, Florence Boissiere, Jun Horiguchi, Tetsunari Oyama, Ken Shirabe, Jacques Colinge, et al. Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-β activity and CD8+ T-cell infiltration in breast cancer. Theranostics. 2024. 14. 5. 1873-1885
-
Sasagu Kurozumi, Naohiko Seki, Eriko Narusawa, Chikako Honda, Shoko Tokuda, Yuko Nakazawa, Takehiko Yokobori, Ayaka Katayama, Nigel P Mongan, Emad A Rakha, et al. Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer. International journal of molecular sciences. 2023. 25. 1
-
Kuo JiueLan, Chikako Sekine, Sasagu Kurozumi, Ryosuke Matsuoka, Mina Komuta, Takayuki Shiomi, Jun Horiguchi. Fibrocystic breast disease with pleomorphic calcifications and segmental distribution: A case report. Radiology case reports. 2023. 18. 11. 3828-3830
ｍore...
MISC (323)：
-
牧口貴哉, 中村英玄, 山口高広, 正田晃基, 黒住献, 黒住献, 堀口淳, 藤井孝明, 上谷大介, 池谷真, et al. iPS細胞由来の間葉系幹細胞を付加した脂肪移植に関する基礎研究. 日本形成外科学会基礎学術集会プログラム・抄録集. 2023. 32nd
-
黒住 献, 丹治 寛子, 田尻 良登, 松岡 亮介, 片山 彩香, 関根 速子, 小無田 美菜, 潮見 隆之, 小山 徹也, 堀口 淳. 【乳がん診療の進歩と展望】乳がんにおけるHER2評価の新展開. 腫瘍内科. 2022. 30. 2. 164-168
-
本田 周子, 黒住 献, 片山 彩香, 中澤 祐子, 荻野 美里, 尾林 紗弥香, 矢島 玲奈, 落合 亮, 横堀 武彦, Ball Graham, et al. 浸潤性乳癌における誘導性共刺激因子(Inducible Co Stimulator;ICOS)発現の臨床病理学的重要性について. 日本乳癌学会総会プログラム抄録集. 2022. 30回. OS2-4
-
成澤 瑛理子, 片山 彩香, 黒住 献, 鯉淵 幸生, 小川 晃, 高他 大輔, 徳田 尚子, 関根 速子, 落合 亮, 潮見 隆之, et al. トリプルネガティブ乳癌におけるHER2-heterogeneityに関する臨床病理学的検討. 日本乳癌学会総会プログラム抄録集. 2022. 30回. EP6-41
-
黒住 献, 関根 速子, 松岡 亮介, 小無田 美菜, 潮見 隆之, 堀口 淳. 乳癌内分泌療法の課題と展望 ER陽性HER2陰性早期浸潤性乳癌における新たな薬物治療ストラテジー. 日本内分泌外科学会雑誌. 2022. 39. Suppl.1. S124-S124
ｍore...
Professional career (1)：
Return to Previous Page
